Health Care

Big pharma accused of price gouging life-saving drugs

Last January, shortly before his presidency began, Donald Trump promised to end big pharmaceutical companies’ stranglehold on drug prices and the healthcare industry; but more than a year later, drug companies continue to face almost no competition while steadily raising their prices.

Edmunds Sizes Up New Car-Safety Technology

We are in a new era of car safety: The focus has shifted from reducing death and injury in a vehicle collision to preventing a crash from happening in the first place.

Kohl's and Sucampo climb while Apple and Qorvo stumble

Stocks that moved substantially or traded heavily Tuesday: Sucampo Pharmaceuticals Inc. (SCMP) The constipation and irritable bowel syndrome drugmaker agreed to be bought by Mallinckrodt for $18 a share, or $839 million.